Harrow, Inc. Common Stock (HROW)
Harrow, Inc. (HROW) is a medical technology company specializing in the development and commercialization of advanced microneedle-based systems for the delivery of pharmaceuticals, vaccines, and other therapeutics. The company's innovative approaches aim to improve patient care through minimally invasive, pain-free, and efficient drug administration methods. Harrow's products are designed to enhance compliance, reduce administration costs, and expand access to vital treatments.
Company News
Harrow is raising $250 million through senior unsecured notes due in 2030, with plans to repay existing debt and potentially fund future business development opportunities.
U.S. stock futures were flat on Tuesday as investors remained cautious ahead of the FOMC meeting. Analysts say the only certainty is that 'things will remain uncertain for the time being'.
Harrow (HROW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The company increased guidance, acquired a company, and had a stock sale.